Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations.
about
Screening for oesophageal cancerEsophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countriesBarrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillanceImpact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.Barrett's oesophagus: epidemiology, cancer risk and implications for management.CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.Healthcare resource use and medical costs for the management of oesophageal cancer.Screening and surveillance for Barrett's esophagus: current issues and future directions.Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?Molecular biomarkers and ablative therapies for Barrett's esophagus.Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy.High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett's esophagus.Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia.Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.Endoscopy screening effect on stage distributions of esophageal cancer: A cluster randomized cohort study in China.
P2860
Q24202341-66670B0B-5B46-48DE-BA83-82911E4C9D0EQ26799758-C46E7AFA-2F12-4C5D-8875-384CEA583F77Q27008431-6A5F30BC-4221-4E3F-8B42-2D55FC1620FDQ30544316-D1A04C25-2DE4-4A86-9659-D02BF9AB3E25Q34331368-B78BFA9D-1118-43EE-AA47-30DC0D7AE75FQ34375216-E46EA058-63F9-4C21-BAE2-3FEC2C426B10Q36119748-62666127-25F6-4ACE-B34F-58586AA3D7BFQ37953412-100F7BBD-5522-433A-A27D-548BDDDC59DEQ38003072-55FD8938-289E-47B1-93DB-9E3CBBD75966Q38031599-DECE354E-C4F3-4745-A3E9-50B33E9E2AECQ38035457-17B99FD8-CA87-42C8-89E2-6E705AE4F84AQ38051702-99B230FF-4F7B-4E40-8C18-2C1F0BA39805Q38192838-38AFEDB5-6D20-4BE5-AF23-578CA9EFF29BQ38328606-6070ADEE-388E-4085-860C-CFF35A3FB6A6Q38813673-3C15F57A-93AC-4B98-89D0-C075C5A88327Q45330160-FEE8324B-1163-429D-9F7F-99E438644E95Q48435798-2200568A-8141-4790-8BA1-2A4448879D5FQ51325667-823C0019-D551-436A-AC59-2AAEF1C40B2DQ55290151-BF348D36-48F2-42D3-B7E3-C506E0D2551F
P2860
Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is endoscopic surveillance for ...... eview of economic evaluations.
@en
Is endoscopic surveillance for ...... eview of economic evaluations.
@nl
type
label
Is endoscopic surveillance for ...... eview of economic evaluations.
@en
Is endoscopic surveillance for ...... eview of economic evaluations.
@nl
prefLabel
Is endoscopic surveillance for ...... eview of economic evaluations.
@en
Is endoscopic surveillance for ...... eview of economic evaluations.
@nl
P2860
P50
P1476
Is endoscopic surveillance for ...... Review of economic evaluations
@en
P2093
Jan J Barendregt
Nicholas G Hirst
P2860
P304
P356
10.1111/J.1440-1746.2010.06506.X
P577
2011-02-01T00:00:00Z